House of Lords written question – answered on 9th July 2014.
Alert me about debates like this
To ask Her Majesty’s Government what advice the Clinical Priorities Advisory Group received about the routine use of Duodopa for advanced Parkinson's disease.
We understand that the Clinical Priorities Advisory Group considered evidence on the clinical effectiveness and estimated costs of Duodopa. NHS England plans to publish a commissioning policy statement for Duodopa in due course.
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
Making it easy to keep an eye on the UK’s parliaments. Discover who represents you, how they’ve voted and what they’ve said in debates – simply and clearly.
Get insights on TheyWorkForYou and other mySociety sites, in our popular newsletter
Your donations keep this site and others like it running
mySociety is a registered charity in England and Wales (1076346) and a limited company (03277032). We provide commercial services through our wholly owned subsidiary SocietyWorks Ltd (05798215).